STOCK TITAN
  1. Home
  2. News
  3. BNGO

Bionano to Report First Quarter 2023 Financial Results and Host a Conference Call and Webcast on May 9, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Bionano Genomics will host a conference call and webcast on May 9, 2023, to report financial results for Q1 2023 and highlight recent corporate progress.
Positive
  • Investors can access a live webcast of the call on the Bionano website.
Negative
  • None.

SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023, at 4:30 p.m. Eastern Time to report financial results for the first quarter 2023 and to highlight recent corporate progress.

Conference Call & Webcast Details

Date:Tuesday, May 9th, 2023
Time:4:30 p.m. ET
Live call:Toll-Free: (800) 715-9871
Conference ID: 4068548
Webcast:https://edge.media-server.com/mmc/p/tw7qar43

Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.

CONTACTS

Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com

Investor Relations:
David Holmes
Gilmartin Group
+1 (858) 888-7625
IR@bionano.com


Bionano Genomics will report its financial results for Q1 2023 on May 9, 2023.

Investors can access a live webcast of the conference call on the Investors page of the Bionano website.

The conference call and webcast will be archived on Bionano's investor relations website for at least 30 days.
Stock BNGO logo
Bionano Genomics Inc

NASDAQ:BNGO

BNGO Rankings

#4742 Ranked by Market Cap
#5501 Ranked by Stock Gains
N/A Ranked by Dividends

BNGO Latest News

Apr 24, 2024
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
Apr 17, 2024
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
Apr 11, 2024
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
Apr 4, 2024
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Apr 3, 2024
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

BNGO Stock Data

Testing Laboratories
Professional, Scientific, and Technical Services
Link
Health Technology, Biotechnology, Professional, Scientific, and Technical Services, Testing Laboratories
US
San Diego

About BNGO

at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o